Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Acta Neuropathol. 2022 Aug 26;144(4):677–690. doi: 10.1007/s00401-022-02476-7

Fig. 4.

Fig. 4

Recombinant WT PFFs induce neurological disease in TgM20+/− mice. Eight-week-old TgM20+/− mice were inoculated with either control patient samples (C9 and C17) or recombinant WT PFFs. Kaplan–Meier plot of disease onset in TgM20+/− mice shows control-inoculated mice did not develop disease by 475 days postinoculation (dpi), but WT PFF-inoculated mice developed overt motor deficits 210 ± 37 dpi (*** = P < 0.001)